NCT07283731
- Conditions
- Advanced/Metastatic, Neoplasm Metastasis, Neoplasms, +10 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Zanzalintinib
Explore clinical trials studying Zanzalintinib. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study